|
1
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen DX and Massagué J: Genetic
determinants of cancer metastasis. Nat Rev Genet. 8:341–352. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monteiro J and Fodde R: Cancer stemness
and metastasis: Therapeutic consequences and perspectives. Eur J
Cancer. 46:1198–1203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deep G and Agarwal R: Antimetastatic
efficacy of silibinin: Molecular mechanisms and therapeutic
potential against cancer. Cancer Metastasis Rev. 29:447–463. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sadler GJ, Anderson MR, Moss MS and Wilson
PG: Metastases from renal cell carcinoma presenting as
gastrointestinal bleeding: Two case reports and a review of the
literature. BMC Gastroenterol. 7:42007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Czarnecka AM, Kornakiewicz A, Kukwa W and
Szczylik C: Frontiers in clinical and molecular diagnostics and
staging of metastatic clear cell renal cell carcinoma. Future
Oncol. 10:1095–1111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010.
|
|
9
|
Patil S, Manola J, Elson P, Negrier S,
Escudier B, Eisen T, Atkins M, Bukowski R and Motzer RJ:
Improvement in overall survival of patients with advanced renal
cell carcinoma: Prognostic factor trend analysis from an
international data set of clinical trials. J Urol. 188:2095–2100.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buti S, Bersanelli M, Sikokis A, Maines F,
Facchinetti F, Bria E, Ardizzoni A, Tortora G and Massari F:
Chemotherapy in metastatic renal cell carcinoma today? A systematic
review. Anticancer Drugs. 24:535–554. 2013.PubMed/NCBI
|
|
11
|
Lin J, Deng Z, Tanikawa C, Shuin T, Miki
T, Matsuda K and Nakamura Y: Downregulation of the tumor suppressor
HSPB7, involved in the p53 pathway, in renal cell carcinoma by
hypermethylation. Int J Oncol. 44:1490–1498. 2014.PubMed/NCBI
|
|
12
|
Kim DW, Ko SM, Jeon YJ, Noh YW, Choi NJ,
Cho SD, Moon HS, Cho YS, Shin JC, Park SM, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013.PubMed/NCBI
|
|
13
|
Joo YN, Eun SY, Park SW, Lee JH, Chang KC
and Kim HJ: Honokiol inhibits U87MG human glioblastoma cell
invasion through endothelial cells by regulating membrane
permeability and the epithelial-mesenchymal transition. Int J
Oncol. 44:187–194. 2014.
|
|
14
|
Tian W, Deng Y, Li L, He H, Sun J and Xu
D: Honokiol synergizes chemotherapy drugs in multidrug resistant
breast cancer cells via enhanced apoptosis and additional
programmed necrotic death. Int J Oncol. 42:721–732. 2013.
|
|
15
|
Hahm ER, Sakao K and Singh SV: Honokiol
activates reactive oxygen species-mediated cytoprotective autophagy
in human prostate cancer cells. Prostate. 74:1209–1221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lai YJ, Lin CI, Wang CL and Chao JI:
Expression of survivin and p53 modulates honokiol-induced apoptosis
in colorectal cancer cells. J Cell Biochem. 115:1888–1899.
2014.PubMed/NCBI
|
|
17
|
Chilampalli C, Zhang X, Kaushik RS, Young
A, Zeman D, Hildreth MB, Fahmy H and Dwivedi C: Chemopreventive
effects of combination of honokiol and magnolol with α-santalol on
skin cancer developments. Drug Discov Ther. 7:109–115.
2013.PubMed/NCBI
|
|
18
|
Liang WZ, Chou CT, Chang HT, Cheng JS, Kuo
DH, Ko KC, Chiang NN, Wu RF, Shieh P and Jan CR: The mechanism of
honokiol-induced intracellular Ca(2+) rises and apoptosis in human
glioblastoma cells. Chem Biol Interact. 221:13–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Beitler JJ, Wang H, Lee MJ, Huang
W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, et al:
Honokiol enhances paclitaxel efficacy in multi-drug resistant human
cancer model through the induction of apoptosis. PLoS One.
9:e863692014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang KH, Yan MD, Yao CJ, Lin PC and Lai
GM: Honokiol-induced apoptosis and autophagy in glioblastoma
multiforme cells. Oncol Lett. 6:1435–1438. 2013.PubMed/NCBI
|
|
21
|
Pan HC, Lai DW, Lan KH, Shen CC, Wu SM,
Chiu CS, Wang KB and Sheu ML: Honokiol thwarts gastric tumor growth
and peritoneal dissemination by inhibiting Tpl2 in an orthotopic
model. Carcinogenesis. 34:2568–2579. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin S, Lamb HK, Brady C, Lefkove B,
Bonner MY, Thompson P, Lovat PE, Arbiser JL, Hawkins AR and Redfern
CP: Inducing apoptosis of cancer cells using small-molecule plant
compounds that bind to GRP78. Br J Cancer. 109:433–443. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao CJ, Lai GM, Yeh CT, Lai MT, Shih PH,
Chao WJ, Whang-Peng J, Chuang SE and Lai TY: Honokiol eliminates
human oral cancer stem-like cells accompanied with suppression of
Wnt/β-catenin signaling and apoptosis induction. Evid Based
Complement Alternat Med. 2013:1461362013. View Article : Google Scholar
|
|
24
|
Chae JI, Jeon YJ and Shim JH:
Downregulation of Sp1 is involved in honokiol-induced cell cycle
arrest and apoptosis in human malignant pleural mesothelioma cells.
Oncol Rep. 29:2318–2324. 2013.PubMed/NCBI
|
|
25
|
Wang Y, Zhu X, Yang Z and Zhao X: Honokiol
induces caspase-independent paraptosis via reactive oxygen species
production that is accompanied by apoptosis in leukemia cells.
Biochem Biophys Res Commun. 430:876–882. 2013. View Article : Google Scholar
|
|
26
|
Avtanski DB, Nagalingam A, Bonner MY,
Arbiser JL, Saxena NK and Sharma D: Honokiol inhibits
epithelial-mesenchymal transition in breast cancer cells by
targeting signal transducer and activator of transcription
3/Zeb1/E-cadherin axis. Mol Oncol. 8:565–580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh T and Katiyar SK: Honokiol inhibits
non-small cell lung cancer cell migration by targeting
PGE2-mediated activation of β-catenin signaling. PLoS
One. 8:e607492013. View Article : Google Scholar
|
|
28
|
Liu SH, Wang KB, Lan KH, Lee WJ, Pan HC,
Wu SM, Peng YC, Chen YC, Shen CC, Cheng HC, et al: Calpain/SHP-1
interaction by honokiol dampening peritoneal dissemination of
gastric cancer in nu/nu mice. PLoS One. 7:e437112012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeong JJ, Lee JH, Chang KC and Kim HJ:
Honokiol exerts an anticancer effect in T98G human glioblastoma
cells through the induction of apoptosis and the regulation of
adhesion molecules. Int J Oncol. 41:1358–1364. 2012.PubMed/NCBI
|
|
30
|
Singh T and Katiyar SK: Honokiol, a
phytochemical from Magnolia spp., inhibits breast cancer cell
migration by targeting nitric oxide and cyclooxygenase-2. Int J
Oncol. 38:769–776. 2011.PubMed/NCBI
|
|
31
|
Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL,
Chen XC, Wang YS, Li J, Chen P, Tang MH, et al: Liposomal honokiol
inhibits VEGF-D-induced lymphangiogenesis and metastasis in
xenograft tumor model. Int J Cancer. 124:2709–2718. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shigemura K, Arbiser JL, Sun SY, Zayzafoon
M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE and Chung
LW: Honokiol, a natural plant product, inhibits the bone metastatic
growth of human prostate cancer cells. Cancer. 109:1279–1289. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li W, Wang Q, Su Q, Ma D, An C, Ma L and
Liang H: Honokiol suppresses renal cancer cells’ metastasis via
dual-blocking epithelial-mesenchymal transition and cancer stem
cell properties through modulating miR-141/ZEB2 signaling. Mol
Cells. 37:383–388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Modulation of human renal cell carcinoma
786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Med Oncol. 23:245–250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lloyd FP Jr, Slivova V, Valachovicova T
and Sliva D: Aspirin inhibits highly invasive prostate cancer
cells. Int J Oncol. 23:1277–1283. 2003.PubMed/NCBI
|
|
36
|
Slivova V, Valachovicova T, Jiang J, et
al: Ganoderma lucidum inhibits invasiveness of breast cancer cells.
J Cancer Integr Med. 2:25–30. 2004.
|
|
37
|
Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu
A and Sliva D: Triterpenes from Poria cocos suppress growth and
invasiveness of pancreatic cancer cells through the downregulation
of MMP-7. Int J Oncol. 42:1869–1874. 2013.PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
39
|
Jiang J, Slivova V, Harvey K,
Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of
breast cancer cells through the inhibition of Akt/NF-kappaB
signaling. Nutr Cancer. 49:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Yusenko MV and Kovacs G: Lack of
KISS1R expression is associated with rapid progression of
conventional renal cell carcinomas. J Pathol. 223:46–53. 2011.
View Article : Google Scholar
|
|
41
|
Zhang H, Guo Y, Shang C, Song Y and Wu B:
miR-21 down-regulated TCF21 to inhibit KISS1 in renal cancer.
Urology. 80:1298–302.e1. 2012. View Article : Google Scholar
|
|
42
|
Hurst DR and Welch DR: Metastasis
suppressor genes at the interface between the environment and tumor
cell growth. Int Rev Cell Mol Biol. 286:107–180. 2011.PubMed/NCBI
|
|
43
|
Lee JH, Miele ME, Hicks DJ, Phillips KK,
Trent JM, Weissman BE and Welch DR: KiSS-1, a novel human malignant
melanoma metastasis-suppressor gene. J Natl Cancer Inst.
88:1731–1737. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Beck BH and Welch DR: The KISS1 metastasis
suppressor: A good night kiss for disseminated cancer cells. Eur J
Cancer. 46:1283–1289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ohtaki T, Shintani Y, Honda S, Matsumoto
H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, et
al: Metastasis suppressor gene KiSS-1 encodes peptide ligand of a
G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shoji S, Tang XY, Umemura S, Itoh J,
Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, et
al: Metastin inhibits migration and invasion of renal cell
carcinoma with overexpression of metastin receptor. Eur Urol.
55:441–449. 2009. View Article : Google Scholar
|
|
47
|
Arora S, Singh S, Piazza GA, Contreras CM,
Panyam J and Singh AP: Honokiol: A novel natural agent for cancer
prevention and therapy. Curr Mol Med. 12:1244–1252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang X, Duan X, Yang G, Zhang X, Deng L,
Zheng H, Deng C, Wen J, Wang N, Peng C, et al: Honokiol crosses BBB
and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral
gliosarcoma model and human U251 xenograft glioma model. PLoS One.
6:e184902011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yoshioka K, Ohno Y, Horiguchi Y, Ozu C,
Namiki K and Tachibana M: Effects of a KiSS-1 peptide, a metastasis
suppressor gene, on the invasive ability of renal cell carcinoma
cells through a modulation of a matrix metalloproteinase 2
expression. Life Sci. 83:332–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cvetković D, Babwah AV and Bhattacharya M:
Kisspeptin/KISS1R System in breast cancer. J Cancer. 4:653–661.
2013. View
Article : Google Scholar
|
